Thursday, 9 April 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 09 April 2026
News

Novo goes solo on PBS

Posted 30 June 2020

Novo Nordisk's latest type two diabetes shot Ozempic has secured a PBS berth four months after final recommendation, with the company already geared up for the launch.

While the government committed to keep new PBS listings rolling during Covid, the lone July addition leaves a backlog of drugs sitting in the final stage before listing and a large number more failing to progress as the PBAC prepares to meet next week to consider the next bundle of submissions.

To see the whole article, please login

Popular

Trump tariffs unleash hidden chaos
What Chat says about your drugs
Four brands hit with price cuts
Marketers 'not quite up to notch'
Latest Jobs
Pharma in Focus  Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home